E
Euglena
Biotech & Life Sciences · Tokyo, Japan · Founded 2005 · IPO 2012 Thoroughbred
Global footprint
Where Euglena has talent and traffic
team presence
across markets
Capital deployed
Euglena's 4 investments and acquisitions.
Every disclosed deal where Euglena appeared as a backer or acquirer, 2016–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
4 deals across Euglena's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
Euglena's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Euglena
An AI-synthesized read of the highest-engagement posts about Euglena on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Euglena on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.